Recombinant human annexin 5 protein (Yabao Pharmaceuticals)
重组人膜联蛋白A5（亚宝药业）
Report date: 2026/02/05 10:06:49
First In Class
Base Information
Drug NameRecombinant human annexin 5 protein (Yabao Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLawson Health Research Institute
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A